Treatment of chronic alopecia areata with tildrakizumab: an open-label pilot study. Kerkemeyer KLS, Sinclair R. Int J Dermatol 2020;59:e136-e137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kerkemeyer KLS, Sinclair R. Treatment of chronic alopecia areata with tildrakizumab: an open-label pilot study. Int J Dermatol 2020;59:e136-e137.
PMID: 32124974